Review: Chemotherapy in newly diagnosed primary central nervous system lymphoma

by Nooshin Hashemi-Sadraei, David M. Peereboom
Published 2010-07-01

Aberrant Signaling Pathways in Squamous Cell Lung Carcinoma

by Ivy Shi, Nooshin Hashemi Sadraei, Zhong-Hui Duan, Ting Shi
Published 2011-01-01

Aberrant Signaling Pathways in Squamous Cell Lung Carcinoma

by Ivy Shi, Nooshin Hashemi Sadraei, Zhong-Hui Duan, Ting Shi
Published 2011-11-01

Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma

by Trisha Wise-Draper, Arun Sendilnathan, Sarah Palackdharry, Nicholas Pease, Julianne Qualtieri, Randall Butler, Nooshin Hashemi Sadraei, John C. Morris, Yash Patil, Keith Wilson, Jonathan Mark, Keith Casper, Vinita Takiar, Adam Lane, Lisa Privette Vinnedge
Published 2018-02-01

359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results

by Hui Yang, Stephane Champiat, Ramaswamy Govindan, Ravi Salgia, Fiona Blackhall, Everett Vokes, Michael Boyer, Marie-Anne Damiette Smit, Melissa Johnson, Hossein Borghaei, Luis Paz-Ares Rodrigues, Rene Boosman, Horst-Dieter Hummel, W Victoria Lai, Hibiki Udagawa, Anne Chiang, Christine Hann, Mukul Minocha, Nooshin Hashemi-Sadraei, Aditya Shetty, Taofeek Owonikoko
Published 2020-11-01